dir celllabeling solution (Thermo Fisher)
Structured Review
Dir Celllabeling Solution, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dir+solution/pm36008710-249-8-12
Average 86 stars, based on 1 article reviews
Images
Related Articles
Labeling:Article Title: PEGylated β-Cell-Targeting Exosomes from Mesenchymal Stem Cells Improve β Cell Function and Quantity by Suppressing NRF2-Mediated Ferroptosis Article Snippet: .. MSC-EXOs and Apt-EXOs were labeled with DIO cell-labeling solution (Invitrogen, V22886, USA) for in vitro studies and with infrared Article Title: PEGylated β-Cell-Targeting Exosomes from Mesenchymal Stem Cells Improve β Cell Function and Quantity by Suppressing NRF2-Mediated Ferroptosis Article Snippet: .. Cellular Internalization of Exosomes MSC-EXOs and Apt-EXOs were labeled with DIO cell-labeling solution (Invitrogen, V22886, USA) for in vitro studies and with infrared In Vitro:Article Title: PEGylated β-Cell-Targeting Exosomes from Mesenchymal Stem Cells Improve β Cell Function and Quantity by Suppressing NRF2-Mediated Ferroptosis Article Snippet: .. MSC-EXOs and Apt-EXOs were labeled with DIO cell-labeling solution (Invitrogen, V22886, USA) for in vitro studies and with infrared Article Title: Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Article Snippet: Although stimulator of interferon genes (STING) agonists has shown great promise in preclinical studies, the clinical development of STING agonist therapy is challenged by its limited systemic delivery.. Here, positively charged fusogenic liposomes loaded with a STING agonist (PoSTING) are designed for systemic delivery and to preferentially target the tumor microenvironment.. When PoSTING is administered intravenously, it selectively targets not only tumor cells but also immune and tumor endothelial cells (ECs). Article Title: PEGylated β-Cell-Targeting Exosomes from Mesenchymal Stem Cells Improve β Cell Function and Quantity by Suppressing NRF2-Mediated Ferroptosis Article Snippet: .. Cellular Internalization of Exosomes MSC-EXOs and Apt-EXOs were labeled with DIO cell-labeling solution (Invitrogen, V22886, USA) for in vitro studies and with infrared In Vivo:Article Title: PEGylated β-Cell-Targeting Exosomes from Mesenchymal Stem Cells Improve β Cell Function and Quantity by Suppressing NRF2-Mediated Ferroptosis Article Snippet: .. MSC-EXOs and Apt-EXOs were labeled with DIO cell-labeling solution (Invitrogen, V22886, USA) for in vitro studies and with infrared Article Title: Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Article Snippet: Although stimulator of interferon genes (STING) agonists has shown great promise in preclinical studies, the clinical development of STING agonist therapy is challenged by its limited systemic delivery.. Here, positively charged fusogenic liposomes loaded with a STING agonist (PoSTING) are designed for systemic delivery and to preferentially target the tumor microenvironment.. When PoSTING is administered intravenously, it selectively targets not only tumor cells but also immune and tumor endothelial cells (ECs). Article Title: PEGylated β-Cell-Targeting Exosomes from Mesenchymal Stem Cells Improve β Cell Function and Quantity by Suppressing NRF2-Mediated Ferroptosis Article Snippet: .. Cellular Internalization of Exosomes MSC-EXOs and Apt-EXOs were labeled with DIO cell-labeling solution (Invitrogen, V22886, USA) for in vitro studies and with infrared Liposomes:Article Title: Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Article Snippet: Although stimulator of interferon genes (STING) agonists has shown great promise in preclinical studies, the clinical development of STING agonist therapy is challenged by its limited systemic delivery.. Here, positively charged fusogenic liposomes loaded with a STING agonist (PoSTING) are designed for systemic delivery and to preferentially target the tumor microenvironment.. When PoSTING is administered intravenously, it selectively targets not only tumor cells but also immune and tumor endothelial cells (ECs). Cell Culture:Article Title: Methods for generating therapeutic delivery platforms Article Snippet: Once the cell cultures reached ̃70% confluency, the media was replaced with fresh media containing 10% exosome-depleted FBS (Thermo Fisher, A2720803). .. The cells were cultured for an additional 72 h before the conditioned media were collected. sEVs were isolated using Nanopoms approach. sEVs were incubated with 1 mM Isolation:Article Title: Methods for generating therapeutic delivery platforms Article Snippet: Once the cell cultures reached ̃70% confluency, the media was replaced with fresh media containing 10% exosome-depleted FBS (Thermo Fisher, A2720803). .. The cells were cultured for an additional 72 h before the conditioned media were collected. sEVs were isolated using Nanopoms approach. sEVs were incubated with 1 mM Incubation:Article Title: Methods for generating therapeutic delivery platforms Article Snippet: Once the cell cultures reached ̃70% confluency, the media was replaced with fresh media containing 10% exosome-depleted FBS (Thermo Fisher, A2720803). .. The cells were cultured for an additional 72 h before the conditioned media were collected. sEVs were isolated using Nanopoms approach. sEVs were incubated with 1 mM Article Title: Anticancer effect of hUC-MSC-derived exosome-mediated delivery of PMO-miR-146b-5p in colorectal cancer. Article Snippet: .. Purified exosomes (5.0 × 109 particles/mL) were incubated with 1 μM other:Article Title: IL-11-Engineered Macrophage Membrane-Coated Reactive Oxygen Species-Responsive Nanoparticles for Targeted Delivery of Doxorubicin to Osteosarcoma. Article Snippet: Osteosarcoma (OS) is a lethal malignant orthotopic bone tumor that primarily affects children and adolescents.. Biomimetic nanocarriers have attracted wide attention as a new strategy for delivering chemotherapy agents to the OS.. However, challenges such as rapid clearance and limited targeting hinder the effectiveness of OS chemotherapy. Article Title: Histone deacetylase inhibition enhances extracellular vesicles from muscle to promote osteogenesis via miR-873-3p Article Snippet: To track EV distribution, 100 μg of Purification:Article Title: Anticancer effect of hUC-MSC-derived exosome-mediated delivery of PMO-miR-146b-5p in colorectal cancer. Article Snippet: .. Purified exosomes (5.0 × 109 particles/mL) were incubated with 1 μM Centrifugation:Article Title: Anticancer effect of hUC-MSC-derived exosome-mediated delivery of PMO-miR-146b-5p in colorectal cancer. Article Snippet: .. Purified exosomes (5.0 × 109 particles/mL) were incubated with 1 μM |
